This study systematically elucidates the multifaceted role of the lactylation-associated enzyme AKR1A1 in the pathogenesis of osteoporosis and, for the first time, proposes that it orchestrates disease progression through metabolic reprogramming, immune modulation, and intercellular communication. This evidence concerns the gene AKR1A1 and osteoporosis.